Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies

The devastating economic and public health consequences caused by the COVID-19 pandemic have prompted outstanding efforts from the scientific community and pharmaceutical companies to develop antibody-based therapeutics against SARS-CoV-2. Those efforts are encouraging and fruitful. An unprecedented...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qingrui, Han, Xiaonan, Yan, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553185/
https://www.ncbi.nlm.nih.gov/pubmed/36106670
http://dx.doi.org/10.1080/22221751.2022.2125348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553185/
https://www.ncbi.nlm.nih.gov/pubmed/36106670
http://dx.doi.org/10.1080/22221751.2022.2125348

Ejemplares similares